PATENT CLAIM ANALYSIS

Application Number: 15881962
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-10
Patent Classification: ["514", "292000"]

Abstract:
The specification relates to compounds of Formula (I): and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of cell proliferative disorders.

Claim (Index 34):
A pharmaceutical composition, which comprises the compound according to  claim 33 , or a pharmaceutically acceptable salt thereof, in association with a pharmaceutically-acceptable excipient.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 86.0
- Lexical Diversity: 1.25714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15657395', '14972326', '14287332', '15445000', '14840342']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8088191544369622
- 35 USC 102 Novelty (BERT): 0.5968293752228133
- Combined Prediction Score: 0.7876201765155474
- Mean Citation Score: 454.349862
- Max Citation Score: 509.77255
- Similarity Product: 449.28030942855776

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test